There’s a wonderful reason why Eisai doesn’t include the word “pharmaceuticals” in its corporate name: The company looks beyond the provision of medicines, taking a big-picture approach to health and focusing on the long-term goals of patients and their families.
With a human health care philosophy that aligns beautifully with family physicians, Eisai joined the AAFP Foundation Partners Program in 2017 and then quickly increased its support, stepping up to the Champion level, a $75,000 annual contribution. As a Champion, Eisai supports the AAFP Foundation’s commitment to physician education, which provides much-needed expertise in such areas as insomnia and Alzheimer’s disease.
In 2020, the Eisai USA Foundation Inc. also provided essential support for our philanthropic efforts, donating $30,000 to the COVID-19 Emergency Relief Fund; the donation supported Family Medicine Cares USA grants to free health clinics.
With roots in Japan, Eisai’s corporate history goes back 80 years. As a leader and innovator, Eisai has dedicated more than 30 years to research, development and commercialization toward the advancement of treatments for Alzheimer’s disease and dementia.
The AAFP Foundation thanks Eisai for its ongoing, generous support, and invites others to learn more about the AAFP Foundation Partner Program.